RUNX1 and breast cancer: Browne et al., utilizing the MMTV-PyMT transgenic mouse model, demonstrated that RUNX1 not only fosters tumor invasion and metastasis in breast cancer but also revealed its heightened expression in distal lung metastatic lesions [157].